Lung resection surgery in Jehovah’s Witness patients: a 20-year single-center experience

Background The paucity of literature on surgical outcomes of Jehovah’s Witness (JW) patients undergoing lung resection suggests some patients with operable lung cancers may be denied resection.

The aim of this study is to better understand perioperative outcomes and long-term cancer survival of JW patients undergoing lung resection.

Methods All pulmonary resections in JW patients at one institution from 2000 through 2020 were examined.

Demographics, comorbidities, operative parameters, and perioperative outcomes were reviewed.

Among operations performed for primary non-small cell lung cancer (NSCLC), details regarding staging, extent of resection, additional therapies, recurrence, and survival were abstracted.

Results Seventeen lung resections were performed in fourteen patients.

There were nine anatomic resections and eight wedge resections.

Fourteen resections (82%) were approached thoracoscopically, of which 3 of 6 anatomic resections were converted to thoracotomy as compared to 1 of 8 wedge resections.

There was one (6%) perioperative death.

Ten resections in 8 patients were performed for primary pulmonary malignancies, and two patients underwent procedures for recurrent disease.

Median survival for resected NSCLCs (N = 7) was 65 months.

Three of 6 patients who survived the immediate perioperative period underwent additional procedures: 2 pulmonary wedge resections for diagnosis and one pleural biopsy.

Conclusions This series of JW patients undergoing lung resections demonstrates that resections for cancer and inflammatory etiologies can be performed safely in the setting of both primary and re-operative procedures.